BR112019011966A2 - composição aprimorada de lansoprazol e simeticona e processo para preparação - Google Patents

composição aprimorada de lansoprazol e simeticona e processo para preparação Download PDF

Info

Publication number
BR112019011966A2
BR112019011966A2 BR112019011966-3A BR112019011966A BR112019011966A2 BR 112019011966 A2 BR112019011966 A2 BR 112019011966A2 BR 112019011966 A BR112019011966 A BR 112019011966A BR 112019011966 A2 BR112019011966 A2 BR 112019011966A2
Authority
BR
Brazil
Prior art keywords
microgranules
simethicone
lansoprazole
high concentration
fact
Prior art date
Application number
BR112019011966-3A
Other languages
English (en)
Portuguese (pt)
Inventor
Alejandro Fiore Esteban
Original Assignee
Siegfried Rhein, S.A. De C.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Siegfried Rhein, S.A. De C.V. filed Critical Siegfried Rhein, S.A. De C.V.
Publication of BR112019011966A2 publication Critical patent/BR112019011966A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/695—Silicon compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/80—Polymers containing hetero atoms not provided for in groups A61K31/755 - A61K31/795
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
BR112019011966-3A 2016-12-14 2017-12-13 composição aprimorada de lansoprazol e simeticona e processo para preparação BR112019011966A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
MXMX/A/2016/016587 2016-12-14
MX2016016587A MX2016016587A (es) 2016-12-14 2016-12-14 Composicion mejorada de lansoprazol y simeticona y procesos para prepararla.
PCT/IB2017/057904 WO2018109693A1 (es) 2016-12-14 2017-12-13 Composición mejorada de lansoprazol y simeticona y proceso para prepararla

Publications (1)

Publication Number Publication Date
BR112019011966A2 true BR112019011966A2 (pt) 2019-11-05

Family

ID=62558163

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112019011966-3A BR112019011966A2 (pt) 2016-12-14 2017-12-13 composição aprimorada de lansoprazol e simeticona e processo para preparação

Country Status (9)

Country Link
AR (1) AR110183A1 (es)
BR (1) BR112019011966A2 (es)
CL (1) CL2019001462A1 (es)
CO (1) CO2019006693A2 (es)
CR (1) CR20190290A (es)
DO (1) DOP2019000145A (es)
MX (1) MX2016016587A (es)
PE (1) PE20191654A1 (es)
WO (1) WO2018109693A1 (es)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5073384A (en) * 1989-10-19 1991-12-17 Valentine Enterprises, Inc. Maltodextrin/defoaming composition combinate
US6103260A (en) * 1997-07-17 2000-08-15 Mcneil-Ppc, Inc. Simethicone/anhydrous calcium phosphate compositions
US7101573B2 (en) * 2001-09-28 2006-09-05 Mcneil-Pcc, Inc. Simethicone solid oral dosage form
US20050181052A1 (en) * 2004-02-17 2005-08-18 Patel Satishkumar A. Lansoprazole microtablets
WO2008056200A1 (en) * 2006-11-10 2008-05-15 Ranbaxy Laboratories Limited Oral pharmaceutical compositions of simethicone
BR112014014278A2 (pt) * 2011-12-14 2017-06-13 Disphar Int B V composição farmacêutica

Also Published As

Publication number Publication date
AR110183A1 (es) 2019-03-06
WO2018109693A1 (es) 2018-06-21
MX2016016587A (es) 2018-06-13
DOP2019000145A (es) 2019-08-15
CO2019006693A2 (es) 2019-07-10
PE20191654A1 (es) 2019-11-07
CR20190290A (es) 2019-11-18
CL2019001462A1 (es) 2019-08-23

Similar Documents

Publication Publication Date Title
ES2389844T3 (es) Forma de dosificación sólida que comprende inhibidor de la bomba de protones, y suspensión obtenida de ella
RU2240110C2 (ru) Новый препарат
ES2529570T3 (es) Formulaciones multiparticuladas de pantoprazol
US20080274200A1 (en) Dose titratable liquid dosage forms of acid labile drugs
ES2961850T3 (es) Minimización de la aireación de suspensiones durante la mezcla en línea
CA2490145C (en) Use of a fast dissolving tablet of a proton pump inhibitor (ppi) to produce a liquid formulation for the treatment of gastrointestinal disorders
US20100009003A1 (en) Pharmaceutical preparation to be dispersed before administration
JPH08253413A (ja) 低分子量薬物経口徐放性製剤
JP2013028603A (ja) プロトンポンプ阻害剤の液体剤形
ES2202915T3 (es) Composiciones farmaceuticas que comprenden zafirlukast.
CN114652684B (zh) 固体药物组合物及其制法
BR112019011966A2 (pt) composição aprimorada de lansoprazol e simeticona e processo para preparação
CN114272233A (zh) 一种奥司他韦组合物及其制备方法
CN106176622A (zh) 一种治疗高血压的异钩藤碱缓释制剂及其制备方法
CN107625733B (zh) 一种克拉霉素无水吞服颗粒剂及其制备方法
CN115040482B (zh) 用于治疗高血压的厄贝沙坦脂质体、制剂及其制备方法
EP2808019B1 (en) Improved nitazoxanide composition and preparation method thereof
BR112018068155B1 (pt) Forma de dosagem de liberação prolongada de múltiplas unidades de cisteamina, cistamina ou sais farmaceuticamente aceitáveis das mesmas
JPH03101615A (ja) 胃内滞留型持続性製剤

Legal Events

Date Code Title Description
B350 Update of information on the portal [chapter 15.35 patent gazette]
B06W Patent application suspended after preliminary examination (for patents with searches from other patent authorities) [chapter 6.23 patent gazette]